> home | Our Partners | Scientific Expertises

SCIENTIFIC EXPERTISE

Referent Experts


Dr. Laurence Watier

Referent biostatistician for the BIRDY project.      

                                        


Statistician and epidemiologist, MPH, PhD, HDR. LW joined the"Pharmacoepidemiology and Infectious Diseases" research group in September 2008. Her work focuses on the choice of statistical methods for

analyzing correlated data and methodological developments for time-series analysis. Her principal field of research is the public-health impact of changes in exposure to antimicrobial drugs.

 




Dr. Benoit Garin
Referent microbiologist for the BIRDY project.                                                         



Medical and food hygiene biologist. Dr Garin has been working in the Institut Pasteur International Network since 1992, he has been involved in studies focused on food contamination and bacterial resistance to antibiotics concerning Mycobacterium tuberculosis, Streptococcus pneumonia, Streptococcus agalactiae, Staphylococcus aureus, Enterobacteria.





Dr. Elsa Kermorvant

Referent pediatrician for the BIRDY project.                                                         



Pediatrician, MD, PhD is neonatologist at NeckerHospital and assistant professor at Paris Descartes University. She joined the BIRDY program as a research advising pediatrician.




Members of the Scientific Advisory Board




Dr. Michel Cot

                                        


Michel Cot, MD, PhD, Directeur de Recherche at IRD, is a medical epidemiologist who has been working on malaria and pregnancy for over 25 years. He has set up cohorts of pregnant women and newborn children, and multicenter clinical trials to protect pregnant women from malaria infection (by either chemoprophylaxis or intermittent preventive treatment –IPTp-), recently evaluating the interest of mefloquine as a replacement drug for IPTp. He has also been studying the genetic susceptibility to malaria, and has played an important role in establishing in the 1990’s the genetic control of blood infection levels in human malaria. He is currently working with immunologists to elucidate the mechanisms associated with protection from and susceptibility to malaria. Since 2009, he has been focusing on the etiologies and consequences of maternal anemia in Africa. He is involved as coordinator in several projects in West Africa, funded by EDCTP(EC), LSTM, Sidaction.




Ramanan Laxminarayan



Senior Research Scholar and Lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. Dr. Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine.





Dr. Iruka N. Okeke




Iruka N. Okeke is professor of microbiology at Haverford College, PA.She received a Bachelor of Pharmacy, Masters and Doctorate degrees from ObafemiAwolowo University Nigeria and was a Fulbright pre-doctoral fellow at theUniversity of Maryland. Her laboratory studies bacterial colonization and isalso engaged in studying antimicrobial resistance and the molecularepidemiology of enteric pathogens. She has served as a consultant onantimicrobial resistance for the Alliance for Prudent Use of Antibiotics, theCenters for Disease Control and Prevention, the Disease Control PrioritiesProject, the Center for Global Development and the World Health Organization.





Prof. Timothy Walsh




Timothy Walsh is the professor of MedicalMicrobiology and Antimicrobial Resistance at Cardiff University.  Prof. Walsh's research is focused on unusualmechanisms of antimicrobial resistance and how they are spread onceestablished.  He has published over 140 papers in the following areas:molecular typing of pathogenic strains, epidemiology of resistance,resistant-gene expression, molecular and biochemical characterisation ofresistant determinants, structural analysis of resistant determinants andevaluation of new methods for discriminating resistant determinants. His research has been funded by the Wellcome Trust, European Union, British Society of Antimicrobial Chemotherapy, BBSRC, Merck, Jones Microbiology Institute, and others.